Daphnetin
2024-HS-012
Approved small_molecule active
Quick answer
Daphnetin for Lower Extremity Lymphedema is a Approved program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Lower Extremity Lymphedema
- Phase
- Approved
- Modality
- small_molecule
- Status
- active